US 7422738
Combined cancer treatment methods using antibodies to aminophospholipids
granted A61KA61K2039/505A61K38/00
Quick answer
US patent 7422738 (Combined cancer treatment methods using antibodies to aminophospholipids) held by The Board of Regents of the University of Texas System expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Sep 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 53
- CPC classes
- A61K, A61K2039/505, A61K38/00, A61K47/6849, A61K49/04